Alvotech (ALVO) Invested Capital (2020 - 2026)
Alvotech (ALVO) posted Invested Capital of $42.5 million for Q1 2026, down 96.73% on a QoQ basis from $1.3 billion in Q4 2025, and up 29.81% year-over-year from $32.8 million in Q1 2025.
Alvotech (ALVO) Invested Capital (2020 - 2026) Analysis & Trends
Alvotech's Invested Capital history runs 7 years deep, the most recent figure standing at $42.5 million for Q1 2026.
- Quarterly Invested Capital rose 29.81% year-over-year to $42.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.4 billion (down 32.61% YoY) and the FY2025 annual result came in at $1.3 billion, up 21.57% from the prior year.
- Invested Capital was $42.5 million for Q1 2026 at Alvotech, down from $1.3 billion in the prior quarter.
- Across five years, Invested Capital topped out at $1.3 billion in Q4 2025 and bottomed at $22.2 million in Q3 2024.
- A 5-year average of $391.5 million and a median of $44.4 million in 2025 frame the typical range for Invested Capital.
- Annual changes were most pronounced in 2024 — Invested Capital soared 4347.47% — and 2025, when it plunged 95.39%.
- Alvotech's Invested Capital stood at $764.6 million in 2022, then grew by 25.58% to $960.2 million in 2023, then gained by 11.29% to $1.1 billion in 2024, then grew by 21.57% to $1.3 billion in 2025, then sank by 96.73% to $42.5 million in 2026.
- Business Quant data shows ALVO's Invested Capital at $42.5 million in Q1 2026, $1.3 billion in Q4 2025, and $42.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 1.11 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 2.61 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 31.13 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 7.15 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.93 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 73.00 Mn |
| 10 | Alvotech | 935.87 Mn | 935.87 Mn | 5.09 Mn | 42.51 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 42.51 Mn |
| Dec 31, 2025 | 1.30 Bn |
| Sep 30, 2025 | 42.72 Mn |
| Jun 30, 2025 | 46.03 Mn |
| Mar 31, 2025 | 32.75 Mn |
| Dec 31, 2024 | 1.07 Bn |
| Sep 30, 2024 | 22.22 Mn |
| Jun 30, 2024 | 999.04 Mn |
| Mar 31, 2024 | 37.55 Mn |
| Dec 31, 2023 | 960.16 Mn |
| Jun 30, 2023 | 22.46 Mn |
| Mar 31, 2023 | 23.05 Mn |
| Dec 31, 2022 | 764.57 Mn |
| Jun 30, 2022 | 120.84 Mn |
| Dec 31, 2021 | 400.91 Mn |
| Dec 31, 2020 | 567.90 Mn |